Alembic — 360° view

Alembic, a company in the Residential, Commercial Projects industry, reported revenue of ₹30 crore and net profit of ₹163 crore for the September 2026 quarter.

Alembic (NSE: ALEMBICLTD) closed at ₹108.91 on 20 Nov 2026, up 10.1% over the past year. Its market capitalisation is ₹2,797 crore and it trades at 7.9 times earnings.

Share price
₹108.91 (20 Nov 2026)
Market cap
₹2,797 Cr (20 Nov 2026)
P/E
7.88 (20 Nov 2026)
Revenue
₹30 Cr (September 2026 quarter)
Net profit
₹163 Cr (September 2026 quarter)
ROCE
6.07% (FY26)
ROE
13.0% (FY26)
Book value
₹104 (FY26)
Dividend yield
2.20% (last 12 months to 20 Nov 2026)
52-week high / low
₹118.23 / ₹70.46 (20 Nov 2026)
1-year return
10.1% (to 20 Nov 2026)
Sector
Consumer Discretionary
Industry
Residential, Commercial Projects
Symbol
NSE: ALEMBICLTD

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group. With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.